A few weeks ago, our porphyria community received bad news. The U.S. Food and Drug Administration (FDA) issued a complete response letter to Disc Medicine’s new drug application for bitopertin, an experimental oral therapy designed to treat erythropoietic protoporphyria (EPP) or X-linked protoporphyria. This means the FDA rejected…
Discussion
I began experiencing symptoms of acute intermittent porphyria (AIP) in July 2020 and was diagnosed three months later. I consider my early diagnosis a blessing, as some people with porphyria wait up to 15 years for an answer. If AIP didn’t run in my family, I might not have…
A young woman in Portugal was diagnosed with acute hepatic porphyria (AHP) after developing persistent abdominal pain and vomiting along with severe hyponatremia — dangerously low sodium levels in the blood — a case report shows. Doctors ruled out more common causes before targeted testing confirmed the diagnosis,…
The U.S. Food and Drug Administration (FDA) has rejected an application from Disc Medicine seeking accelerated approval of its experimental oral therapy bitopertin as a treatment for erythropoietic protoporphyria (EPP). According to Disc, the FDA said available clinical data aren’t sufficient to conclude that bitopertin is likely to…
Becoming educated and informed about porphyria is a good first step. Here you’ll find general information about the disease, including the types, diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of some of our columnist’s words of wisdom to help you along on your porphyria journey.
There is no cure for porphyria yet, but there are therapies that can help manage the disease. Here you can find more information about some of the approved treatments for porphyria.
Get regular updates to your inbox.
